在国家人口中开发一种可解释的机器学习喘预测模型,使用血清制阻燃剂
Xin Pan1,2, Qiong Wang1,3, Che Li4,5
1Graduate School, Beijing University of Chinese Medicine, Beijing, China.
Clinical and experimental medicine
|October 25, 2025
概括
血清化阻燃剂 (BFR) 代谢物与成人喘风险有关. 机器学习模型,特别是XGBoost,使用BFR概况有效预测喘,有助于早期预防和管理.
科学领域:
- 环境健康 环境健康
- 毒理学 毒理学 毒理学
- 流行病学 流行病学
背景情况:
- 制阻燃剂 (BFR) 是广泛使用的化学品,具有潜在的健康影响.
- 暴露于环境污染物如BFRs被假设为导致呼吸系统疾病如喘.
- 了解与喘风险相关的特定BFR及其代谢物概况对于公共卫生至关重要.
研究的目的:
- 调查血清BFR代谢物水平和混合物概况与美国成年人喘风险之间的关联.
- 开发和验证一种可解释的机器学习模型,以基于BFR暴露来预测喘.
- 通过使用先进的分析方法,识别导致喘风险的关键BFR.
主要方法:
- 利用了国家健康和营养检查调查 (NHANES) 的数据,涵盖1999-2023年,包括9948名美国成年人.
- 采用了四种机器学习算法 (光梯度增强机,XGBoost,随机森林,神经网络) 与夏普利增量扩展 (SHAP) 和后勤回归.
- 确定了喘的显著预测因素,包括人口统计,生活方式和血清BFR代谢物数据.
主要成果:
- XGBoost模型实现了最高的预测性能,曲线下的面积 (AUC) 为0.814.
- 包括家族史,BMI和特定BFR (PBDE47,PBDE28,PBDE154,PBDE153, PBB153) 在内的16个特征被确定为重要的预测因素.
- 五个关键的BFR (PBDE47,PBDE28,PBDE154,PBDE153, PBB153) 被SHAP分析强调为喘风险的主要贡献者.
结论:
- 基于血清BFR代谢物概况,XGBoost机器学习模型有效地预测成人喘.
- 这种方法为早期喘预防,风险分层和临床管理提供了有前途的工具.
- 对BFR暴露和喘病原体的进一步研究是有必要的.
相关概念视频
Asthma-I: Introduction
3.4K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.4K
Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K


